Novant Health Oncology Specialists
Clinical research site in Winston-Salem, North Carolina
As of September 2026, 4 paid clinical trials are recruiting at Novant Health Oncology Specialists in Winston-Salem, North Carolina. Active studies at this site cover conditions such as Ovarian Cancer, Breast Neoplasms and Non-small Cell Lung Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Novant Health Oncology Specialists (4)
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Get new-trial alerts for Novant Health Oncology Specialists
We'll email you whenever a new clinical trial starts recruiting at this research site in Winston-Salem, NC. Unsubscribe anytime.
More research sites in Winston-Salem
- Wake Forest University Health Sciences (160 trials)
- Atrium Health Wake Forest Baptist (48 trials)
- Wake Forest University (23 trials)
- Novant Health Forsyth Medical Center (20 trials)
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center (19 trials)
- Wake Forest Baptist Comprehensive Cancer Center (19 trials)
- Atrium Health Wake Forest Baptist Medical Center (17 trials)
- Wake Forest Baptist Medical Center (14 trials)
- Wake Forest Baptist Health (11 trials)
- Wake Forest University School of Medicine (10 trials)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.
Explore more
Paid clinical trials in Winston-Salem, NC · North Carolina clinical trials